Back to Search
THOMAS RAGOLE, MD
MD
Neurology Physician
NPI: 1437577897IndividualAccepts Medicare
Specialties, Licenses & Credentials
Neurology PhysicianPrimary
Psychiatry & Neurology — Neurology
Code: 2084N0400X
MD192817(OR)DR.0064958(CO)
Education
UNIVERSITY OF COLORADO SCHOOL OF MEDICINE, AURORA
Class of 2014
Clinical Trials (1)
1
Linked Trials
1
Recruiting
0
With Results
Research & Publications (20)
Hospitalizations and Mortality From Myasthenia Gravis: Trends From 2 US National Datasets
PMID 38165317·Neurology·2024
8-other
How should newer therapeutic agents be incorporated into the treatment of patients with myasthenia gravis?
PMID 38308492·Muscle Nerve·2024
8-other
Safety and efficacy of rozanolixizumab in patients with generalised myasthenia gravis (MycarinG): a randomised, double-blind, placebo-controlled, adaptive phase 3 study.
PMID 37059507·Lancet Neurol·2023
2-rct
Randomized Double-Blind Placebo-Controlled Trial of the Corticosteroid-Sparing Effects of Immunoglobulin in Myasthenia Gravis.
PMID 36270895·Neurology·2023
2-rct
Adverse Events and Infectious Complications in the Critically Ill Treated by Plasma Exchange: A Five-Year Multicenter Cohort Study.
PMID 38304709·Crit Care Explor·2023
8-other
Terminal Complement Inhibitor Ravulizumab in Generalized Myasthenia Gravis.
PMID 38319212·NEJM Evid·2022
2-rct
Therapeutic Plasma Exchange in Myasthenia Gravis: A Systematic Literature Review and Meta-Analysis of Comparative Evidence.
PMID 34531809·Front Neurol·2021
1-meta
Safety, efficacy, and tolerability of efgartigimod in patients with generalised myasthenia gravis (ADAPT): a multicentre, randomised, placebo-controlled, phase 3 trial.
PMID 34146511·Lancet Neurol·2021
3-trial
Comparison of Corticosteroid Tapering Regimens in Myasthenia Gravis: A Randomized Clinical Trial.
PMID 33555314·JAMA Neurol·2021
4-observational
Randomized phase 2 study of FcRn antagonist efgartigimod in generalized myasthenia gravis.
PMID 31118245·Neurology·2019
3-trial
Understanding the burden of refractory myasthenia gravis.
PMID 30854027·Ther Adv Neurol Disord·2019
6-review
Neonatal Fc receptor antagonist efgartigimod safely and sustainably reduces IgGs in humans.
PMID 30040076·J Clin Invest·2018
2-rct
Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study.
PMID 29066163·Lancet Neurol·2017
3-trial
Effect of therapeutic plasma exchange on immunoglobulins in myasthenia gravis.
PMID 27684107·Autoimmunity·2016
8-other
Minimal clinically important difference in myasthenia gravis: outcomes from a randomized trial.
PMID 24810970·Muscle Nerve·2014
2-rct
Therapeutic plasma exchange in patients with neurological diseases: multicenter retrospective analysis.
PMID 23619327·Transfus Apher Sci·2013
4-observational
Intravenous immunoglobulin for myasthenia gravis.
PMID 23235588·Cochrane Database Syst Rev·2012
1-meta
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 12401 E 17TH AVE
AURORA, CO 80045 - Phone
- (720) 848-0000
Quick Facts
- NPI
- 1437577897
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 1
- Years in Practice
- 12
- Clinical Trials
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile